Clincosm LogoSign in Get a demo

Dry Eye Syndrome

Showing NaN - NaN of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Syndrome Trial in United States (Low Dose - SkQ1, High dose - SkQ1, SkQ1 (Vehicle))

Completed
Has Results
  • Dry Eye Syndrome
  • Low Dose - SkQ1
  • +2 more
  • Phoenix, Arizona
  • +6 more
Dec 20, 2021

Dry Eye Syndrome Trial in United States (SkQ1 Vehicle Solution, SkQ1 Ophthalmic Solution)

Completed
Has Results
  • Dry Eye Syndrome
  • SkQ1 Vehicle Solution
  • SkQ1 Ophthalmic Solution
  • Sun City West, Arizona
  • +3 more
Dec 20, 2021

Dry Eye Syndrome Trial in Andover (RGN-259, Placebo)

Completed
Has Results
  • Dry Eye Syndrome
  • Andover, Massachusetts
    Andover, MA
Dec 9, 2021

Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,

Completed
Has Results
  • Dry Eye Syndrome
  • Keratoconjunctivitis Sicca
  • 0.05% Voclosporin Ophthalmic Solution (VOS)
  • +3 more
  • Newport Beach, California
  • +8 more
Dec 8, 2021

Dry Eye Syndrome Trial in United States (BRM421, Placebo)

Completed
Has Results
  • Dry Eye Syndrome
  • Newport Beach, California
  • +3 more
Sep 24, 2021

Dry Eye Syndrome Trial in Andover (RGN-259, Placebo)

Completed
  • Dry Eye Syndrome
  • Andover, Massachusetts
    Andover, MA
Oct 7, 2019

Dry Eye Syndrome Trial in United States (TOP1630 0.1% Ophthalmic Solution TID OU, Placebo to TOP1630 0.1% Ophthalmic Solution

Completed
  • Dry Eye Syndrome
  • TOP1630 0.1% Ophthalmic Solution TID OU
  • Placebo to TOP1630 0.1% Ophthalmic Solution TID OU
  • Lewiston, Maine
  • +3 more
Aug 6, 2019

Dry Eye Syndrome Trial in United States (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.1%), Vehicle

Completed
  • Dry Eye Syndrome
  • Reproxalap Ophthalmic Solution (0.25%)
  • +2 more
  • Waterbury, Connecticut
  • +5 more
Jul 10, 2019

Dry Eye Syndrome Trial in Andover (TOP1630 Ophthalmic Solution, Placebo to TOP1630 Ophthalmic Solution)

Completed
  • Dry Eye Syndrome
  • TOP1630 Ophthalmic Solution
  • Placebo to TOP1630 Ophthalmic Solution
  • Andover, Massachusetts
    Andover Eye Associates
Sep 21, 2018

Dry Eye Syndrome Trial in Lewiston, Andover (BRM421, Placebo)

Completed
  • Dry Eye Syndrome
  • Lewiston, Maine
  • +1 more
Nov 20, 2017

Dry Eye Syndrome Trial in Andover (cis-UCA ophthalmic solution 1.0%, cis-UCA ophthalmic solution 2.5%, Placebo ophthalmic

Completed
  • Dry Eye Syndrome
  • cis-UCA ophthalmic solution 1.0%
  • +2 more
  • Andover, Massachusetts
    (unnamed)
Sep 7, 2015

Dry Eye Syndrome Trial in Andover (PG101)

Completed
  • Dry Eye Syndrome
  • Andover, Massachusetts
    Andover Eye
Mar 3, 2014

Dry Eye Syndrome Trial in Andover (RX-10045, Vehicle for RX-10045)

Completed
  • Dry Eye Syndrome
  • Andover, Massachusetts
    Andover Eye Associates
Feb 7, 2013

Dry Eye Syndrome Trial in Andover (RX-10045, Placebo)

Completed
  • Dry Eye Syndrome
  • Andover, Massachusetts
    ORA Clinical
Sep 20, 2010

Dry Eye Syndrome Trial in Andover, North Andover (EGP-437 with EyeGate® II System, Sodium citrate buffer solution with EyeGate®

Completed
  • Dry Eye Syndrome
  • EGP-437 with EyeGate® II System
  • Sodium citrate buffer solution with EyeGate® II System
  • Andover, Massachusetts
  • +1 more
Aug 27, 2010